Primary Disease: Unresectable or Metastatic Renal Cell Carcinoma Focus of the Study:PFS Assessed by IRC Per RECIST 1.1

DrugDrug NameDrug Description
DrugDrug NameTargetType
DrugDrug NamePhaseStatusCount
DB06626Axitinib3Active Not Recruiting1
DB01268Sunitinib3Active Not Recruiting1
DB15043Toripalimab3Active Not Recruiting1